Jana Halámková

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Paolo Bossi, Anthony T.�C. Chan, Lisa Licitra et al. · Annals of Oncology · 2020 · 424 citations · Full text

Medicine, Oncology, Otolaryngology +14

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

Petra Vychytilova‐Faltejskova, Jana Merhautová, Táňa Macháčková et al. · Oncogenesis · 2017 · 102 citations · Full text

Medicine, Molecular Biology, Oncology +17

Second primary malignancies in colorectal cancer patients

Jana Halámková, Tomáš Kazda, Lucie Pehalová et al. · Scientific Reports · 2021 · 45 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN

Jean‐Yves Blay, Paolo G. Casali, Corinne Bouvier et al. · ESMO Open · 2021 · 36 citations · Full text

Medicine, Oncology, Cancer Epidemiology +15

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients

Jana Halámková, Zdeněk Pavlovský, Jiří Tomášek et al. · Neoplasma · 2011 · 29 citations

Medicine, Oncology, Pharmacology +15